HealthData.Gov
A surrogate-based approach for post-genomic partner identification
Background Modern drug discovery is concerned with identification and validation of novel protein targets from among the 30,000 genes or more postulated to be present in the human genome. While protein-protein…
- HTML
Updated Oct 29, 2026